Journal
CLINICAL CASE REPORTS
Volume 8, Issue 12, Pages 3243-3246Publisher
WILEY
DOI: 10.1002/ccr3.3325
Keywords
atopic dermatitis; dermatology; eczema; JAK inhibitors; tofacitinib
Categories
Ask authors/readers for more resources
Atopic dermatitis (AD) is a common skin disease, associated with high burden impact in quality of live, in moderate-severe disease severity. Several targeted drugs are under development for AD. Here, we present a patient with refractory disease to systemic traditional immunosuppressive drugs, treated successfully with oral tofacitinib, with complete response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available